NCT01222429

Brief Summary

This study aims to test a dietary intervention for diabetes in a medical practice setting, with the aim of developing a model for diabetes care that can be used widely. The investigators hypothesize that a low-fat vegan diet will be effective for management of diabetes and will be feasible in a practice-based setting.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable type-2-diabetes

Timeline
Completed

Started Oct 2010

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2010

Completed
11 days until next milestone

First Submitted

Initial submission to the registry

October 12, 2010

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 18, 2010

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2011

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2012

Completed
Last Updated

August 7, 2012

Status Verified

August 1, 2012

Enrollment Period

8 months

First QC Date

October 12, 2010

Last Update Submit

August 6, 2012

Conditions

Outcome Measures

Primary Outcomes (16)

  • hemoglobin A1C (diabetes management)

    assessment at baseline (0 weeks)

  • hemoglobin A1C (diabetes management)

    assessment at 10 weeks

  • hemoglobin A1C (diabetes management)

    assessment at 20 weeks

  • hemoglobin A1C (diabetes management)

    assessment at one-year follow-up

  • lipid profile (serum cholesterol--total, LDL, HDL; triglycerides)

    assessment at baseline (0 weeks)

  • lipid profile (serum cholesterol--total, LDL, HDL; triglycerides)

    assessment at 10 weeks

  • lipid profile (serum cholesterol--total, LDL, HDL; triglycerides)

    assesment at 20 weeks

  • lipid profile (serum cholesterol--total, LDL, HDL; triglycerides)

    assessment at one-year follow-up

  • body weight

    assessment at baseline (0 weeks)

  • body weight

    assessment at 10 weeks

  • body weight

    assessment at 20 weeks

  • body weight

    assessment at one-year follow-up

  • indices of renal function (serum creatinine, microalbumin)

    assessment at baseline (0 weeks)

  • indices of renal function (serum creatinine, microalbumin)

    assessment at 10 weeks

  • indices of renal function (serum creatinine, microalbumin)

    assessment at 20 weeks

  • indices of renal function (serum creatinine, microalbumin)

    assessment at one-year follow-up

Study Arms (2)

diet following American Diabetes Association guidelines

ACTIVE COMPARATOR

Participants will follow diets based on ADA guidelines. This group will also receive weekly nutrition classes.

Other: diet following ADA guidelines

vegan diet

EXPERIMENTAL

Participants in the intervention group will follow a low-fat, vegan diet for 20 weeks, and will attend nutrition classes in the form of a weekly support group.

Other: vegan diet

Interventions

Intervention group participants will follow a low-fat vegan diet and will receive instruction on this diet through the course of the study

vegan diet

participants will be given instruction on the ADA guidelines for diabetes, and will follow an individualized plan based on these guidelines

diet following American Diabetes Association guidelines

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • a diagnosis of type 2 diabetes mellitus, as defined by a fasting plasma glucose concentration ≥126 mg/dl on 2 occasions or a prior physician's diagnosis of type 2 diabetes with the use of hypoglycemic medications for at least 6 months
  • male or female
  • A1c between 6.5% and 10.5%
  • age at least 18 years
  • ability and willingness to participate in all components of the study
  • willingness to be assigned to either a low-fat, vegan diet or to standard nutrition care
  • diabetes medications unchanged for 1 month prior to volunteering for the study
  • patient of Dr. Mark Sklar

You may not qualify if:

  • body mass index \>45 kg/m2
  • alcohol consumption of more than 2 drinks per day or the equivalent, episodic increased drinking (e.g., more than 2 drinks per day on weekends), or a history of alcohol abuse or dependency followed by any current use
  • pregnancy or plans to become pregnant
  • history of severe mental illness (with current unstable status)
  • likely to be disruptive in group sessions (as determined by research staff)
  • Signs/symptoms of acute uncontrolled diabetes (including but not limited to polyuria, polydipsia, blurred vision, uncontrolled weight loss)
  • unstable medical status
  • already following a low-fat, vegetarian diet
  • an inordinate fear of blood draws
  • inability to maintain current medication regimen
  • lack of English fluency

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Barnard ND, Levin SM, Gloede L, Flores R. Turning the Waiting Room into a Classroom: Weekly Classes Using a Vegan or a Portion-Controlled Eating Plan Improve Diabetes Control in a Randomized Translational Study. J Acad Nutr Diet. 2018 Jun;118(6):1072-1079. doi: 10.1016/j.jand.2017.11.017. Epub 2018 Feb 15.

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Interventions

Diet, Vegan

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Diet, VegetarianDiet, Plant-BasedDiet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Officials

  • Neal D Barnard, MD

    Washington Center for Clinical Research

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
CARE PROVIDER
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 12, 2010

First Posted

October 18, 2010

Study Start

October 1, 2010

Primary Completion

June 1, 2011

Study Completion

February 1, 2012

Last Updated

August 7, 2012

Record last verified: 2012-08